Exact Therapeutics AS (OSL:EXTX) ROE % Adjusted to Book Value : -13.29% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS ROE % Adjusted to Book Value?

Exact Therapeutics AS's ROE % for the quarter that ended in Dec. 2023 was -113.35%. Exact Therapeutics AS's PB Ratio for the quarter that ended in Dec. 2023 was 8.53. Exact Therapeutics AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -13.29%.

Exact Therapeutics AS ROE % Adjusted to Book Value Historical Data

The historical data trend for Exact Therapeutics AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS ROE % Adjusted to Book Value Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.92

-8.96

-8.49

-10.28

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial						-7.53	-8.01	-6.68	-10.35	-13.29

Competitive Comparison of Exact Therapeutics AS's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Exact Therapeutics AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's ROE % Adjusted to Book Value falls into.

Exact Therapeutics AS ROE % Adjusted to Book Value Calculation

Exact Therapeutics AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-87.71%	/	8.53
	=	-10.28%

Exact Therapeutics AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-113.35%	/	8.53
	=	-13.29%

Exact Therapeutics AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines